C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
E Maddaloni, GB Bolli, BM Frier… - Diabetes, Obesity …, 2022 - Wiley Online Library
Impaired beta‐cell function is a recognized cornerstone of diabetes pathophysiology.
Estimates of insulin secretory capacity are useful to inform clinical practice, helping to …
Estimates of insulin secretory capacity are useful to inform clinical practice, helping to …
Latent autoimmune diabetes in adults: current status and new horizons
P Pozzilli, S Pieralice - Endocrinology and Metabolism, 2018 - synapse.koreamed.org
Autoimmune diabetes is a heterogeneous disease which can arise at any age. Subjects with
adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 …
adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 …
Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China Study) a nationwide, multicenter, clinic-based cross …
Z Zhou, Y Xiang, L Ji, W Jia, G Ning, G Huang… - Diabetes, 2013 - Am Diabetes Assoc
Adult non–insulin requiring diabetes includes latent autoimmune diabetes of adults (LADA),
distinguished from type 2 diabetes by the presence of islet autoantibodies. LADA China …
distinguished from type 2 diabetes by the presence of islet autoantibodies. LADA China …
A global perspective of latent autoimmune diabetes in adults
Latent autoimmune diabetes in adults (LADA) is characterized by the presence of islet
autoantibodies and initial insulin independence, which can lead to misdiagnosis of type 2 …
autoantibodies and initial insulin independence, which can lead to misdiagnosis of type 2 …
[PDF][PDF] Latent autoimmune diabetes in adults: a review on clinical implications and management
S Pieralice, P Pozzilli - Diabetes & Metabolism Journal, 2018 - synapse.koreamed.org
Latent autoimmune diabetes in adults (LADA) is a heterogeneous disease characterized by
a less intensive autoimmune process and a broad clinical phenotype compared to classical …
a less intensive autoimmune process and a broad clinical phenotype compared to classical …
Latent autoimmune diabetes in adults in A sians: Similarities and differences between E ast and W est (亚洲成人隐匿性自身免疫糖尿病的特点: 东西方种族差异之比较)
Y Xiang, Z Zhou, C Deng, RD Leslie - Journal of Diabetes, 2013 - Wiley Online Library
摘要成人隐匿性自身免疫糖尿病(LADA) 是自身免疫糖尿病的一种亚型, 处于糖尿病连续疾病谱
的中间, 兼具1 型糖尿病和2 型糖尿病的特征. 目前对于这类糖尿病究竟是否为一种独立的糖尿病 …
的中间, 兼具1 型糖尿病和2 型糖尿病的特征. 目前对于这类糖尿病究竟是否为一种独立的糖尿病 …
Past, present and future of latent autoimmune diabetes in adults
Latent autoimmune diabetes in adults (LADA) is the most common form of autoimmune
diabetes diagnosed in adults. Similar to type 1 diabetes, the prevalence of LADA is impacted …
diabetes diagnosed in adults. Similar to type 1 diabetes, the prevalence of LADA is impacted …
Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus
G Huang, Y Xiang, L Pan, X Li, S Luo… - … research and reviews, 2013 - Wiley Online Library
Abstract Background The ZnT8A is an independent marker for diagnosis of type 1 diabetes
mellitus. We investigated the distribution and clinical features of ZnT8A positive latent …
mellitus. We investigated the distribution and clinical features of ZnT8A positive latent …
Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes
X Tang, X Yan, H Zhou, X Yang, X Niu… - … and Obesity: Targets …, 2019 - Taylor & Francis
Aim This study aimed to estimate the prevalence of latent autoimmune diabetes of adults
(LADA) and classic type 1 diabetes mellitus (T1DM) in newly diagnosed adult diabetes in …
(LADA) and classic type 1 diabetes mellitus (T1DM) in newly diagnosed adult diabetes in …
Latent autoimmune diabetes in adults (LADA) in Asian and European populations
A Kumar, A de Leiva - Diabetes/metabolism research and …, 2017 - Wiley Online Library
Diabetes mellitus is a chronic disorder caused by relative or absolute insulin deficiency and
characterized by chronic hyperglycaemia. It is expected that by year 2025, 80% of all type 2 …
characterized by chronic hyperglycaemia. It is expected that by year 2025, 80% of all type 2 …